US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 30, 2020

USA v. GLENMARK PHARMACEUTICALS, INC., USA

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 21, 2023

    Teva, Glenmark To Pay $305M In Latest DOJ Generics Deal

    The U.S. Department of Justice announced its largest settlement to date Monday in ongoing price-fixing enforcement against major generic-drug companies, with Teva set to pay a $225 million criminal penalty and donate $50 million worth of drugs, while Glenmark plans to pay a $30 million penalty.

22 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login